A French Multi-centric Atrial Fibrillation Catheter Ablation Survey (FrenchAF)
August 6, 2013 updated by: Serge Boveda, Clinique Pasteur
Atrial fibrillation is the most frequent sustained arrhythmia. Catheter ablation is a procedure that is currently used for the treatment of symptomatic atrial fibrillation patients.
We have organized a multi-centric national survey of catheter ablation of atrial fibrillation in order to have a feedback on the type of procedures being performed and the overall results (freedom of atrial fibrillation) over an average follow-up of 18 months.
Study Overview
Status
Unknown
Intervention / Treatment
Study Type
Observational
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Toulouse, France
- Clinique Pasteur
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 90 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
All patients undergoing catheter ablation in one of the registry centers
Description
Inclusion Criteria:
- all patients undergoing catheter ablation of atrial fibrillation or left atrial flutter
Exclusion Criteria:
- patients undergoing catheter ablation of other types of arrhythmia
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Pasteur
|
electric pulmonary vein disconnection
|
|
Grenoble
|
electric pulmonary vein disconnection
|
|
Nantes
|
electric pulmonary vein disconnection
|
|
Parly
|
electric pulmonary vein disconnection
|
|
Rennes
|
electric pulmonary vein disconnection
|
|
Rouen
|
electric pulmonary vein disconnection
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Atrial fibrillation relapse
Time Frame: starting 3 months after the procedure till an average of 18months follow-up
|
Documentation of atrial fibrillation relapse (symptomatic or asymptomatic) after the first 3 months after the index procedure
|
starting 3 months after the procedure till an average of 18months follow-up
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Early atrial fibrillation relapse
Time Frame: first 3 months
|
Documented atrial fibrillation relapse (symptomatic or asymptomatic) in the first 3 months after the index procedure
|
first 3 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
November 1, 2010
Primary Completion (Actual)
July 1, 2013
Study Completion (Anticipated)
December 1, 2013
Study Registration Dates
First Submitted
August 6, 2013
First Submitted That Met QC Criteria
August 6, 2013
First Posted (Estimate)
August 8, 2013
Study Record Updates
Last Update Posted (Estimate)
August 8, 2013
Last Update Submitted That Met QC Criteria
August 6, 2013
Last Verified
August 1, 2013
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- FrenchAFAblationSurvey
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.